IL17A and experimental autoimmune encephalomyelitis: To assess the ability of iTregs to suppress T‐cell responses in vivo, we used a T‐cell model of autoimmunity, experimental autoimmune encephalomyelitis (EAE), in which Th17 CD4+ cells play a critical role in driving disease pathology through IL‐17 secretion.40, 41